NIH Awarded 22% Fewer Grants In 2025, A 24% Drop In Cancer Research

The National Institutes of Health (NIH) has seen a significant decrease in the number of grants awarded this year under the Trump administration. According to an analysis by Aatish Bhatia, Amy Fan, Jonah Smith, and Irena Hwang for The New York Times, only 12,588 NIH grants were awarded this year, compared to an average of 16,099 grants per year from 2015 through 2024.

This reduction in grant funding has far-reaching implications for the future of medical research and treatment. With fewer grants being awarded, there will likely be fewer advancements in the prevention and treatment of various medical conditions, including cancer, diabetes, mental health issues, arthritis, infectious diseases, and more.

The impact of the funding cuts is felt across all areas of science and medicine. Grants for research into cancer have decreased by 24%, mental health by 43%, diabetes by 30%, and various other diseases by significant percentages. This trend is alarming as it indicates a lack of support for crucial areas of research that could lead to breakthroughs in healthcare.

In addition to awarding fewer grants, the NIH has also frozen or canceled over 5,000 grants that had already been awarded. This further hinders progress in medical research and treatment, as researchers are left without the necessary funding to continue their work.

The Trump administration’s policies, including a new multiyear funding policy and cuts to grant completion time, are likely to result in fewer grants being issued in the coming years. These policy changes may override Congress’s wishes and lead to a significant reduction in NIH funding, which could have long-term consequences for medical research.

The cuts to NIH funding may also drive talented scientists away from medical research. The increasing difficulty in securing funding, coupled with stagnant research budgets, could discourage researchers from pursuing careers in medical research. This talent drain could have detrimental effects on America’s competitiveness in the global scientific community and hinder progress in the fight against diseases.

Overall, the decrease in NIH grants awarded this year is a concerning development that could have far-reaching implications for the future of medical research and treatment. It is essential for policymakers to prioritize funding for scientific research to ensure continued progress in healthcare innovation.